Dr. Noah Federman is a Professor of Pediatrics and Orthopaedics at University of California Los

Angeles and Director of the UCLA Pediatric Sarcoma Program. Dr. Federman also Directs the UCLA

Clinical and Translational Research Center. Dr. Federman was one of the investigators in the SCOUT

Phase 1 trial of Larotrectinib in children with NTRK fusion cancers.